Home > Result Summaries: Compounds > abacavir/lamivudine/zidovudine > Result Summary for COL30494

Result Summary for COL30494

Result Summary

Protocol ID:	COL30494
Clinical Study ID:	COL30494
Official Title:	An Open-Label Multicentre Study to Evaluate the Adherence to, General Satisfaction and Quality of Life After 24 Weeks Therapy With a Triple Combination tablet (TRIZIVIR™) [Abacavir, Lamivudine, and Zidovudine] in HIV-1 Infected Subjects With Undetectable Plasma HIV-1 RNA Levels
Phase:	Phase 4
Study Indications or Diseases:	Infection, Human Immunodeficiency Virus I
Generic Name:	abacavir/lamivudine/zidovudine
Trade/Product Name:	trizivir;trizivir
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Clotet B, Carmena J, Pulido F, Luque I., Rodríguez-Alcantara F. Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients. HIV Clin Trials 2004; 5(1):33-39. Adherence to and general satisfaction with Trizivir' in HIV-1 patients B Clotet', F Pulidol J Carmena' 'Germans Trias i Pujol, 6th International Congress on Drug Therapy in HIV Infection; Glasgow; Scotland. 2002 Nov 17